Summary
Research into cancer vaccines has waxed and waned over the years, advancing more slowly than other types of immunotherapy research. Novel approaches are clearly needed. And that’s just what Mayo Clinic investigator Richard G. Vile, Ph.D., is bringing to the table, with ideas that are described as incredibly creative, original and even eccentric. The result is a cancer assassin — a precisely engineered vector that can slip into liver tumors undetected and deliver its genetic payload with minimal harm to the patient.
See more: Mayo Clinic, Scottsdale
Advertisement
